Xtant Medical Holdings, Inc. (XTNT)
| Previous Close | 0.5763 |
| Open | 0.5961 |
| Bid | 0.5601 x 900 |
| Ask | 0.5900 x 1800 |
| Day's Range | 0.5611 - 0.5961 |
| 52 Week Range | 0.5300 - 6.5800 |
| Volume | |
| Avg. Volume | 101,072 |
| Market Cap | 49.491M |
| Beta (5Y Monthly) | 1.46 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0400 |
| Earnings Date | Feb. 22, 2022 - Feb. 28, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
Xtant Medical to Present at the H.C. Wainwright BioConnect Virtual Conference
BELGRADE, Mont., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, Chief Executive Officer, will present at the H.C. Wainwright BioConnect Virtual Conference taking place January 10-13, 2022. A pre-recorded presentation will be available on the Investors section of the Company’s website at www.xtantmedical.com, beginning on
- GlobeNewswire
Xtant Medical Appoints Scott Neils Interim Chief Financial Officer
BELGRADE, Mont., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the appointment of Scott Neils as Interim Chief Financial Officer succeeding Greg Jensen, the Company’s current Vice President, Finance and Chief Financial Officer, effective January 3, 2022. “We are excited to announce this well deserved promotion for Scott. His demonstrated
- GlobeNewswire
Xtant Medical Announces Third Quarter 2021 Financial Results
BELGRADE, Mont., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the third quarter ended September 30, 2021. Third Quarter 2021 Financial Highlights: Revenue for the third quarter of 2021 totaled $13.8 million, compared to $14.0 million for the prior-year periodLoss from operations totaled $1.4 million co
